145 related articles for article (PubMed ID: 17020880)
81. The 1.1 A resolution crystal structure of the p130cas SH3 domain and ramifications for ligand selectivity.
Wisniewska M; Bossenmaier B; Georges G; Hesse F; Dangl M; Künkele KP; Ioannidis I; Huber R; Engh RA
J Mol Biol; 2005 Apr; 347(5):1005-14. PubMed ID: 15784259
[TBL] [Abstract][Full Text] [Related]
82. A mammalian adaptor protein with conserved Src homology 2 and phosphotyrosine-binding domains is related to Shc and is specifically expressed in the brain.
O'Bryan JP; Songyang Z; Cantley L; Der CJ; Pawson T
Proc Natl Acad Sci U S A; 1996 Apr; 93(7):2729-34. PubMed ID: 8610109
[TBL] [Abstract][Full Text] [Related]
83. Sequences surrounding the Src-homology 3 domain of phospholipase Cgamma-1 increase the domain's association with Cbl.
Graham LJ; Stoica BA; Shapiro M; DeBell KE; Rellahan B; Laborda J; Bonvini E
Biochem Biophys Res Commun; 1998 Aug; 249(2):537-41. PubMed ID: 9712732
[TBL] [Abstract][Full Text] [Related]
84. Tyrosine phosphorylation regulates the SH3-mediated binding of the Wiskott-Aldrich syndrome protein to PSTPIP, a cytoskeletal-associated protein.
Wu Y; Spencer SD; Lasky LA
J Biol Chem; 1998 Mar; 273(10):5765-70. PubMed ID: 9488710
[TBL] [Abstract][Full Text] [Related]
85. Identification and functional characterization of an Src homology domain 3 domain-binding site on Cbl.
Sanjay A; Miyazaki T; Itzstein C; Purev E; Horne WC; Baron R
FEBS J; 2006 Dec; 273(23):5442-56. PubMed ID: 17094785
[TBL] [Abstract][Full Text] [Related]
86. Exploring Molecular Contacts of MUC1 at CIN85 Binding Interface to Address Future Drug Design Efforts.
Gulotta MR; Vittorio S; Gitto R; Perricone U; De Luca L
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33672244
[TBL] [Abstract][Full Text] [Related]
87. Disrupting the intramolecular interaction between proto-oncogene c-Src SH3 domain and its self-binding peptide PPII with rationally designed peptide ligands.
Zhou P; Hou S; Bai Z; Li Z; Wang H; Chen Z; Meng Y
Artif Cells Nanomed Biotechnol; 2018 Sep; 46(6):1122-1131. PubMed ID: 28754059
[TBL] [Abstract][Full Text] [Related]
88. Tripartite phase separation of two signal effectors with vesicles priming B cell responsiveness.
Wong LE; Bhatt A; Erdmann PS; Hou Z; Maier J; Pirkuliyeva S; Engelke M; Becker S; Plitzko J; Wienands J; Griesinger C
Nat Commun; 2020 Feb; 11(1):848. PubMed ID: 32051419
[TBL] [Abstract][Full Text] [Related]
89. Adaptor protein complex of FRS2β and CIN85/CD2AP provides a novel mechanism for ErbB2/HER2 protein downregulation.
Minegishi Y; Shibagaki Y; Mizutani A; Fujita K; Tezuka T; Kinoshita M; Kuroda M; Hattori S; Gotoh N
Cancer Sci; 2013 Mar; 104(3):345-52. PubMed ID: 23279575
[TBL] [Abstract][Full Text] [Related]
90. Autoinhibition in the Signal Transducer CIN85 Modulates B Cell Activation.
Sieme D; Engelke M; Rezaei-Ghaleh N; Becker S; Wienands J; Griesinger C
J Am Chem Soc; 2024 Jan; 146(1):399-409. PubMed ID: 38111344
[TBL] [Abstract][Full Text] [Related]
91. Proteome-wide detection of Abl1 SH3-binding peptides by integrating computational prediction and peptide microarray.
Xu Z; Hou T; Li N; Xu Y; Wang W
Mol Cell Proteomics; 2012 Jan; 11(1):O111.010389. PubMed ID: 22023807
[TBL] [Abstract][Full Text] [Related]
92. Expression, purification and preliminary crystallographic studies of the C-terminal SH3 domain of human Tks4.
Huang Y; Qian H; Wang X; Cheng Z; Ren J; Zhao W; Xie Y
Acta Crystallogr F Struct Biol Commun; 2014 Mar; 70(Pt 3):343-6. PubMed ID: 24598923
[TBL] [Abstract][Full Text] [Related]
93. Sleuthing biochemical evidence to elucidate unassigned electron density in a CBL-SLAP2 crystal complex.
Wybenga-Groot LE; McGlade CJ
Acta Crystallogr F Struct Biol Commun; 2021 Feb; 77(Pt 2):37-46. PubMed ID: 33620036
[TBL] [Abstract][Full Text] [Related]
94. Multi-timescale conformational dynamics of the SH3 domain of CD2-associated protein using NMR spectroscopy and accelerated molecular dynamics.
Salmon L; Pierce L; Grimm A; Ortega Roldan JL; Mollica L; Jensen MR; van Nuland N; Markwick PR; McCammon JA; Blackledge M
Angew Chem Int Ed Engl; 2012 Jun; 51(25):6103-6. PubMed ID: 22565613
[No Abstract] [Full Text] [Related]
95. The ORF3 protein of hepatitis E virus delays degradation of activated growth factor receptors by interacting with CIN85 and blocking formation of the Cbl-CIN85 complex.
Chandra V; Kalia M; Hajela K; Jameel S
J Virol; 2010 Apr; 84(8):3857-67. PubMed ID: 20130058
[TBL] [Abstract][Full Text] [Related]
96. Identification of a novel inhibitory actin-capping protein binding motif in CD2-associated protein.
Bruck S; Huber TB; Ingham RJ; Kim K; Niederstrasser H; Allen PM; Pawson T; Cooper JA; Shaw AS
J Biol Chem; 2006 Jul; 281(28):19196-203. PubMed ID: 16707503
[TBL] [Abstract][Full Text] [Related]
97. Proteins recruited by SH3 domains of Ruk/CIN85 adaptor identified by LC-MS/MS.
Havrylov S; Rzhepetskyy Y; Malinowska A; Drobot L; Redowicz MJ
Proteome Sci; 2009 Jun; 7():21. PubMed ID: 19531213
[TBL] [Abstract][Full Text] [Related]
98. Accurate characterization of weak macromolecular interactions by titration of NMR residual dipolar couplings: application to the CD2AP SH3-C:ubiquitin complex.
Ortega-Roldan JL; Jensen MR; Brutscher B; Azuaga AI; Blackledge M; van Nuland NA
Nucleic Acids Res; 2009 May; 37(9):e70. PubMed ID: 19359362
[TBL] [Abstract][Full Text] [Related]
99. Structure of melanoma inhibitory activity protein, a member of a recently identified family of secreted proteins.
Lougheed JC; Holton JM; Alber T; Bazan JF; Handel TM
Proc Natl Acad Sci U S A; 2001 May; 98(10):5515-20. PubMed ID: 11331761
[TBL] [Abstract][Full Text] [Related]
100. In Silico Identification of Potential Druggable Binding Sites on CIN85 SH3 Domain.
Vittorio S; Seidel T; Garon A; Gitto R; Langer T; De Luca L
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33430321
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
